

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 6.24982787 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.19642793 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.81283005 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.81283005 |
| 5 | ensheathment of neurons (GO:0007272) | 5.78178941 |
| 6 | axon ensheathment (GO:0008366) | 5.78178941 |
| 7 | myelination (GO:0042552) | 5.73523881 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.64700263 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.36074260 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35448720 |
| 11 | myelin maintenance (GO:0043217) | 5.04943532 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.78223131 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.60496635 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.53883646 |
| 15 | response to lipoprotein particle (GO:0055094) | 4.52551744 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.39720210 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36049991 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33360755 |
| 19 | detection of other organism (GO:0098543) | 4.31441128 |
| 20 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.22553896 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.19847524 |
| 22 | amyloid precursor protein metabolic process (GO:0042982) | 4.18542402 |
| 23 | response to peptidoglycan (GO:0032494) | 4.17412521 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 4.14674543 |
| 25 | L-amino acid import (GO:0043092) | 4.08125785 |
| 26 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.04369180 |
| 27 | cellular extravasation (GO:0045123) | 3.99177534 |
| 28 | detection of bacterium (GO:0016045) | 3.93386275 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90769967 |
| 30 | creatine metabolic process (GO:0006600) | 3.90171490 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.89792473 |
| 32 | leukocyte aggregation (GO:0070486) | 3.88813365 |
| 33 | oligodendrocyte differentiation (GO:0048709) | 3.88710316 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.88639125 |
| 35 | negative regulation of protein localization to cell surface (GO:2000009) | 3.84240644 |
| 36 | negative T cell selection (GO:0043383) | 3.81997486 |
| 37 | regulation of collateral sprouting (GO:0048670) | 3.81236164 |
| 38 | negative regulation of neurotransmitter transport (GO:0051589) | 3.80375491 |
| 39 | amyloid precursor protein catabolic process (GO:0042987) | 3.79904881 |
| 40 | response to interleukin-15 (GO:0070672) | 3.76084917 |
| 41 | negative thymic T cell selection (GO:0045060) | 3.75068014 |
| 42 | positive regulation of mast cell activation (GO:0033005) | 3.74249801 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.68269769 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66967715 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66657586 |
| 46 | import into cell (GO:0098657) | 3.64578082 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.64526184 |
| 48 | glycerophospholipid catabolic process (GO:0046475) | 3.64448577 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.63575417 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.60432694 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.58441059 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.57695189 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.55835466 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.52344854 |
| 55 | detection of biotic stimulus (GO:0009595) | 3.51527207 |
| 56 | macrophage activation (GO:0042116) | 3.46701918 |
| 57 | cholesterol biosynthetic process (GO:0006695) | 3.46450061 |
| 58 | T cell migration (GO:0072678) | 3.44908087 |
| 59 | positive T cell selection (GO:0043368) | 3.42269436 |
| 60 | response to methylmercury (GO:0051597) | 3.42267047 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 3.41721396 |
| 62 | virion attachment to host cell (GO:0019062) | 3.41721396 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39208308 |
| 64 | response to host immune response (GO:0052572) | 3.39208308 |
| 65 | glycosylceramide metabolic process (GO:0006677) | 3.38873022 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.38758678 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.38559432 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37220123 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.35928900 |
| 70 | positive regulation of mast cell degranulation (GO:0043306) | 3.35541031 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35541031 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35198912 |
| 73 | membrane raft organization (GO:0031579) | 3.34724351 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33956248 |
| 75 | establishment of mitochondrion localization (GO:0051654) | 3.33092100 |
| 76 | regulation of mast cell activation (GO:0033003) | 3.27185971 |
| 77 | tolerance induction (GO:0002507) | 3.22384372 |
| 78 | T cell selection (GO:0045058) | 3.21954284 |
| 79 | neutrophil mediated immunity (GO:0002446) | 3.19846294 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19057605 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19057605 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 3.19057605 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19057605 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 3.19057605 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19057605 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18884642 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.15862015 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14162153 |
| 89 | B cell mediated immunity (GO:0019724) | 3.11989512 |
| 90 | response to muramyl dipeptide (GO:0032495) | 3.11362698 |
| 91 | astrocyte development (GO:0014002) | 3.09437762 |
| 92 | GPI anchor biosynthetic process (GO:0006506) | 3.08514143 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08095566 |
| 94 | sterol biosynthetic process (GO:0016126) | 3.07416343 |
| 95 | response to host (GO:0075136) | 3.07106223 |
| 96 | response to host defenses (GO:0052200) | 3.07106223 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07106223 |
| 98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06761199 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06282077 |
| 100 | positive regulation of interleukin-17 production (GO:0032740) | 3.06043865 |
| 101 | microglial cell activation (GO:0001774) | 3.05912949 |
| 102 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01442460 |
| 103 | interferon-gamma production (GO:0032609) | 3.01279526 |
| 104 | isoprenoid biosynthetic process (GO:0008299) | 3.00004229 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.99991105 |
| 106 | negative regulation of macroautophagy (GO:0016242) | 2.99247412 |
| 107 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.98972812 |
| 108 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98849141 |
| 109 | type I interferon signaling pathway (GO:0060337) | 2.98771723 |
| 110 | cellular response to type I interferon (GO:0071357) | 2.98771723 |
| 111 | neutrophil activation (GO:0042119) | 2.98498916 |
| 112 | regulation of lipoprotein metabolic process (GO:0050746) | 2.98281703 |
| 113 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.97700737 |
| 114 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96860055 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96662561 |
| 116 | eye photoreceptor cell differentiation (GO:0001754) | 2.96492967 |
| 117 | photoreceptor cell differentiation (GO:0046530) | 2.96492967 |
| 118 | regulation of leukocyte degranulation (GO:0043300) | 2.94855592 |
| 119 | response to type I interferon (GO:0034340) | 2.94813446 |
| 120 | defense response to protozoan (GO:0042832) | 2.93844150 |
| 121 | respiratory burst (GO:0045730) | 2.93725341 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93696099 |
| 123 | amino acid import (GO:0043090) | 2.93331221 |
| 124 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92413091 |
| 125 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.91823985 |
| 126 | asymmetric protein localization (GO:0008105) | 2.90999479 |
| 127 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90959290 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90276582 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90276582 |
| 130 | GPI anchor metabolic process (GO:0006505) | 2.90180016 |
| 131 | myeloid leukocyte activation (GO:0002274) | 2.88391235 |
| 132 | positive regulation of glial cell differentiation (GO:0045687) | 2.88153451 |
| 133 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87880448 |
| 134 | positive regulation of gliogenesis (GO:0014015) | 2.87591482 |
| 135 | thymic T cell selection (GO:0045061) | 2.86645773 |
| 136 | regulation of interleukin-17 production (GO:0032660) | 2.86089744 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85941694 |
| 138 | membrane tubulation (GO:0097320) | 2.85598547 |
| 139 | granulocyte activation (GO:0036230) | 2.83177078 |
| 140 | protein palmitoylation (GO:0018345) | 2.80462214 |
| 141 | apical protein localization (GO:0045176) | 2.77147734 |
| 142 | response to redox state (GO:0051775) | 2.74079569 |
| 143 | mast cell activation (GO:0045576) | 2.71147357 |
| 144 | magnesium ion transport (GO:0015693) | 2.70729369 |
| 145 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.70310271 |
| 146 | presynaptic membrane organization (GO:0097090) | 2.68645417 |
| 147 | axon development (GO:0061564) | 2.66788000 |
| 148 | substantia nigra development (GO:0021762) | 2.64384130 |
| 149 | regulation of T cell migration (GO:2000404) | 2.64256687 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.62181561 |
| 151 | negative regulation of acute inflammatory response (GO:0002674) | 2.62044577 |
| 152 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.61748277 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.60788226 |
| 154 | intracellular pH reduction (GO:0051452) | 2.60264531 |
| 155 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.58011030 |
| 156 | macrophage activation involved in immune response (GO:0002281) | 2.55954421 |
| 157 | nerve growth factor signaling pathway (GO:0038180) | 2.55019998 |
| 158 | regulation of lymphocyte migration (GO:2000401) | 2.54793157 |
| 159 | adult walking behavior (GO:0007628) | 2.51451913 |
| 160 | protein localization to endosome (GO:0036010) | 2.51118283 |
| 161 | negative regulation of interleukin-17 production (GO:0032700) | 2.49651554 |
| 162 | activated T cell proliferation (GO:0050798) | 2.47556183 |
| 163 | tissue regeneration (GO:0042246) | 2.46083624 |
| 164 | T-helper 1 type immune response (GO:0042088) | 2.44503812 |
| 165 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.44132089 |
| 166 | pH reduction (GO:0045851) | 2.43736094 |
| 167 | membrane protein ectodomain proteolysis (GO:0006509) | 2.43642562 |
| 168 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.41821492 |
| 169 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.41198714 |
| 170 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.40413098 |
| 171 | positive regulation of T cell cytokine production (GO:0002726) | 2.38959306 |
| 172 | positive regulation of type 2 immune response (GO:0002830) | 2.38689397 |
| 173 | positive regulation of pseudopodium assembly (GO:0031274) | 2.38390210 |
| 174 | neuron remodeling (GO:0016322) | 2.38308010 |
| 175 | cortical actin cytoskeleton organization (GO:0030866) | 2.38235346 |
| 176 | leukocyte degranulation (GO:0043299) | 2.37740433 |
| 177 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.35221217 |
| 178 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32457440 |
| 179 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.30658963 |
| 180 | glial cell development (GO:0021782) | 2.30434928 |
| 181 | central nervous system myelination (GO:0022010) | 10.6952339 |
| 182 | axon ensheathment in central nervous system (GO:0032291) | 10.6952339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.86339081 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22480919 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.77652333 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35227005 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.03867771 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.94824970 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83135845 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.78824249 |
| 9 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.61096860 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56408796 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44280769 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39076413 |
| 13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.35856594 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19838883 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17454982 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15100912 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11719621 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11308622 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10737563 |
| 20 | * MYB_26560356_Chip-Seq_TH1_Human | 2.08492810 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03605102 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.03177228 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94744959 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93349752 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90683709 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83630653 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79892877 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79709830 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78084645 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72729770 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72112674 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.70774043 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69340093 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68490248 |
| 35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66611168 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63359868 |
| 37 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61108247 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60245097 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56320066 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56063742 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53520417 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48470320 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46203435 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45974586 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.44429043 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.43614710 |
| 47 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41123766 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40767656 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40767656 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39119819 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39098237 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38305550 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38049438 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37943542 |
| 55 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37313489 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36970023 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.33456605 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33248680 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32839640 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32628163 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30501880 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29842828 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.29201815 |
| 64 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27135393 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26568991 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26069068 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24327683 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23481631 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23169488 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22067714 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21821423 |
| 72 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21746868 |
| 73 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21585403 |
| 74 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20966644 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17858969 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17369887 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16178299 |
| 78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15254828 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15107375 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14219886 |
| 81 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13261973 |
| 82 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12582568 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11931967 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10639973 |
| 85 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10496832 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10334171 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10104460 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09766658 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09402394 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08842422 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08613320 |
| 92 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07527559 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07475086 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06981812 |
| 95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06097819 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05848820 |
| 97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05532191 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04672827 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03511091 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02134739 |
| 101 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01022362 |
| 102 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00421734 |
| 103 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.00345714 |
| 104 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99940985 |
| 105 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99851559 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99393702 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98337958 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96051646 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95716194 |
| 110 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95110531 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95013026 |
| 112 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94364552 |
| 113 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93589431 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93512282 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93380441 |
| 116 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93022043 |
| 117 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93022043 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91820250 |
| 119 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.91277391 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91126736 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90862638 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90581051 |
| 123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88546183 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87794734 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87777874 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87356765 |
| 127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.87350633 |
| 128 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87322187 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87307007 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86793350 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86534162 |
| 132 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86482599 |
| 133 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86146307 |
| 134 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85354728 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85169276 |
| 136 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85010804 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84692970 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84605848 |
| 139 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84306998 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84075877 |
| 141 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83251250 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82956863 |
| 143 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82349127 |
| 144 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82278780 |
| 145 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.82171213 |
| 146 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.81182903 |
| 147 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80841342 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80778173 |
| 149 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80778173 |
| 150 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.80729386 |
| 151 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80674598 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80661826 |
| 153 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80401831 |
| 154 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80366522 |
| 155 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79449199 |
| 156 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74335438 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71797609 |
| 158 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70443270 |
| 159 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68767733 |
| 160 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68602078 |
| 161 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65720169 |
| 162 | GATA3_26560356_Chip-Seq_TH1_Human | 0.65655794 |
| 163 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.63360113 |
| 164 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61757498 |
| 165 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61237789 |
| 166 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60450943 |
| 167 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.58863340 |
| 168 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.57208974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.74201390 |
| 2 | MP0003690_abnormal_glial_cell | 3.90053897 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.86161060 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.43766830 |
| 5 | MP0006082_CNS_inflammation | 3.26961993 |
| 6 | MP0005171_absent_coat_pigmentation | 2.68417979 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.57540256 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.50826260 |
| 9 | MP0003136_yellow_coat_color | 2.35838043 |
| 10 | MP0003634_abnormal_glial_cell | 2.31357437 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.27266315 |
| 12 | MP0003329_amyloid_beta_deposits | 2.22158332 |
| 13 | MP0003880_abnormal_central_pattern | 2.17588563 |
| 14 | MP0000604_amyloidosis | 2.16160223 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.15545273 |
| 16 | MP0004742_abnormal_vestibular_system | 2.14408692 |
| 17 | MP0002419_abnormal_innate_immunity | 2.12838870 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.12647111 |
| 19 | MP0009840_abnormal_foam_cell | 2.03132933 |
| 20 | MP0002398_abnormal_bone_marrow | 1.94125615 |
| 21 | MP0001790_abnormal_immune_system | 1.89996517 |
| 22 | MP0005387_immune_system_phenotype | 1.89996517 |
| 23 | MP0009785_altered_susceptibility_to | 1.85155368 |
| 24 | MP0001905_abnormal_dopamine_level | 1.83094480 |
| 25 | MP0005671_abnormal_response_to | 1.82763924 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.78737928 |
| 27 | MP0004270_analgesia | 1.76857524 |
| 28 | MP0005409_darkened_coat_color | 1.76688284 |
| 29 | MP0003303_peritoneal_inflammation | 1.75805347 |
| 30 | MP0003724_increased_susceptibility_to | 1.75532262 |
| 31 | MP0004142_abnormal_muscle_tone | 1.73120261 |
| 32 | MP0005025_abnormal_response_to | 1.72679783 |
| 33 | MP0001529_abnormal_vocalization | 1.72403480 |
| 34 | MP0005451_abnormal_body_composition | 1.68320867 |
| 35 | MP0005410_abnormal_fertilization | 1.66532579 |
| 36 | MP0008260_abnormal_autophagy | 1.66293817 |
| 37 | MP0004885_abnormal_endolymph | 1.64049877 |
| 38 | MP0003866_abnormal_defecation | 1.62031004 |
| 39 | MP0009764_decreased_sensitivity_to | 1.61907657 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.61869536 |
| 41 | MP0004381_abnormal_hair_follicle | 1.61475773 |
| 42 | MP0002723_abnormal_immune_serum | 1.59220917 |
| 43 | MP0001851_eye_inflammation | 1.59087362 |
| 44 | MP0003828_pulmonary_edema | 1.58939325 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.57738323 |
| 46 | MP0003436_decreased_susceptibility_to | 1.57207411 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.55690612 |
| 48 | MP0002722_abnormal_immune_system | 1.55215633 |
| 49 | MP0003632_abnormal_nervous_system | 1.54226200 |
| 50 | MP0001853_heart_inflammation | 1.52548044 |
| 51 | MP0002229_neurodegeneration | 1.51448770 |
| 52 | MP0002429_abnormal_blood_cell | 1.50551311 |
| 53 | MP0003075_altered_response_to | 1.50226733 |
| 54 | MP0002272_abnormal_nervous_system | 1.50131772 |
| 55 | MP0000383_abnormal_hair_follicle | 1.49076750 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.48678586 |
| 57 | MP0001486_abnormal_startle_reflex | 1.48421927 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.46253816 |
| 59 | MP0002064_seizures | 1.44099915 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.43442533 |
| 61 | MP0005310_abnormal_salivary_gland | 1.41429111 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.40665030 |
| 63 | MP0001800_abnormal_humoral_immune | 1.39053244 |
| 64 | MP0002933_joint_inflammation | 1.31429179 |
| 65 | MP0003631_nervous_system_phenotype | 1.30679112 |
| 66 | MP0000685_abnormal_immune_system | 1.30134422 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.29003233 |
| 68 | MP0003633_abnormal_nervous_system | 1.28000157 |
| 69 | MP0001819_abnormal_immune_cell | 1.26347916 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.25998890 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.24776554 |
| 72 | MP0009278_abnormal_bone_marrow | 1.24075944 |
| 73 | MP0000858_altered_metastatic_potential | 1.22647781 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.19691813 |
| 75 | MP0004883_abnormal_blood_vessel | 1.16906308 |
| 76 | MP0004043_abnormal_pH_regulation | 1.14999003 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.14400580 |
| 78 | MP0004134_abnormal_chest_morphology | 1.14225180 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.12404092 |
| 80 | MP0003195_calcinosis | 1.11045595 |
| 81 | MP0004510_myositis | 1.10961854 |
| 82 | MP0002006_tumorigenesis | 1.09715318 |
| 83 | MP0001545_abnormal_hematopoietic_system | 1.06857409 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.06857409 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.06675085 |
| 86 | MP0002132_abnormal_respiratory_system | 1.03199449 |
| 87 | MP0002396_abnormal_hematopoietic_system | 1.01541675 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.98221954 |
| 89 | MP0009046_muscle_twitch | 0.95377370 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.95225117 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.94030044 |
| 92 | MP0005164_abnormal_response_to | 0.93514364 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.93022704 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.92850109 |
| 95 | MP0005423_abnormal_somatic_nervous | 0.92635319 |
| 96 | MP0000778_abnormal_nervous_system | 0.92072674 |
| 97 | MP0003045_fibrosis | 0.88449109 |
| 98 | MP0002405_respiratory_system_inflammati | 0.87829654 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.87201837 |
| 100 | MP0009763_increased_sensitivity_to | 0.86497949 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.86135706 |
| 102 | MP0001873_stomach_inflammation | 0.85140673 |
| 103 | MP0008004_abnormal_stomach_pH | 0.84211314 |
| 104 | MP0002009_preneoplasia | 0.84050431 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.80943929 |
| 106 | MP0002090_abnormal_vision | 0.79750639 |
| 107 | MP0000716_abnormal_immune_system | 0.78076999 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.77912294 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.77874443 |
| 110 | MP0000343_altered_response_to | 0.77677670 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.77274506 |
| 112 | MP0008469_abnormal_protein_level | 0.76229336 |
| 113 | MP0003448_altered_tumor_morphology | 0.74212943 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.74147317 |
| 115 | MP0008569_lethality_at_weaning | 0.73537994 |
| 116 | MP0001970_abnormal_pain_threshold | 0.72427827 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.70670687 |
| 118 | MP0005390_skeleton_phenotype | 0.70450642 |
| 119 | MP0002133_abnormal_respiratory_system | 0.68937895 |
| 120 | MP0005388_respiratory_system_phenotype | 0.68937895 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.68766815 |
| 122 | MP0009745_abnormal_behavioral_response | 0.67840124 |
| 123 | MP0000249_abnormal_blood_vessel | 0.67548266 |
| 124 | MP0008874_decreased_physiological_sensi | 0.67290273 |
| 125 | MP0000747_muscle_weakness | 0.67246669 |
| 126 | MP0004947_skin_inflammation | 0.67181118 |
| 127 | MP0005408_hypopigmentation | 0.66852562 |
| 128 | MP0005166_decreased_susceptibility_to | 0.66482074 |
| 129 | MP0005195_abnormal_posterior_eye | 0.66471651 |
| 130 | MP0001663_abnormal_digestive_system | 0.66241454 |
| 131 | MP0004808_abnormal_hematopoietic_stem | 0.66112174 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.65704000 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.65506364 |
| 134 | MP0002882_abnormal_neuron_morphology | 0.65408871 |
| 135 | MP0000462_abnormal_digestive_system | 0.65401666 |
| 136 | MP0003795_abnormal_bone_structure | 0.65299963 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.63968511 |
| 138 | MP0001986_abnormal_taste_sensitivity | 0.54172597 |
| 139 | MP0000371_diluted_coat_color | 0.53421153 |
| 140 | MP0008873_increased_physiological_sensi | 0.52269387 |
| 141 | MP0004130_abnormal_muscle_cell | 0.52145568 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.51028469 |
| 143 | MP0006054_spinal_hemorrhage | 0.49827483 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.47154149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.26699553 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.86761293 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.86761293 |
| 4 | Myositis (HP:0100614) | 5.12252135 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.81415260 |
| 6 | Optic neuritis (HP:0100653) | 4.81415260 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.74127546 |
| 8 | Orchitis (HP:0100796) | 4.72980021 |
| 9 | Parakeratosis (HP:0001036) | 4.61380317 |
| 10 | Axonal loss (HP:0003447) | 4.59461423 |
| 11 | T lymphocytopenia (HP:0005403) | 4.42114073 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 4.25879461 |
| 13 | Abnormality of T cell number (HP:0011839) | 4.24360552 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.22644526 |
| 15 | Peripheral hypomyelination (HP:0007182) | 4.14320183 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.13897574 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 4.10586915 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.99233517 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.90437895 |
| 20 | Meningitis (HP:0001287) | 3.87070737 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.83762300 |
| 22 | Onion bulb formation (HP:0003383) | 3.78899999 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77898443 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77898443 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77469960 |
| 26 | Hepatosplenomegaly (HP:0001433) | 3.71928194 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.70980709 |
| 28 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.65700727 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.64437063 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.63851759 |
| 31 | Sensory axonal neuropathy (HP:0003390) | 3.56682489 |
| 32 | Vasculitis (HP:0002633) | 3.51960483 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.49520388 |
| 34 | Encephalitis (HP:0002383) | 3.49325768 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.49109569 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.48849581 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.46405977 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 3.42972654 |
| 39 | Recurrent viral infections (HP:0004429) | 3.30781370 |
| 40 | Spontaneous hematomas (HP:0007420) | 3.29706392 |
| 41 | Abnormality of T cells (HP:0002843) | 3.28205961 |
| 42 | Hemoptysis (HP:0002105) | 3.24234170 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.21674559 |
| 44 | Gingivitis (HP:0000230) | 3.18318811 |
| 45 | Abnormal auditory evoked potentials (HP:0006958) | 3.11017204 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10361774 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10361774 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10361774 |
| 49 | Stomatitis (HP:0010280) | 3.07780625 |
| 50 | Leukocytosis (HP:0001974) | 3.02620638 |
| 51 | Urticaria (HP:0001025) | 2.98692055 |
| 52 | Chest pain (HP:0100749) | 2.96399164 |
| 53 | Loss of speech (HP:0002371) | 2.94619251 |
| 54 | Pulmonary embolism (HP:0002204) | 2.94232893 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.93580335 |
| 56 | Slow saccadic eye movements (HP:0000514) | 2.90951325 |
| 57 | Clumsiness (HP:0002312) | 2.88472929 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.86582178 |
| 59 | Increased IgM level (HP:0003496) | 2.83994724 |
| 60 | Arterial thrombosis (HP:0004420) | 2.75522537 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.73689811 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.73261715 |
| 63 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.73046953 |
| 64 | Spastic gait (HP:0002064) | 2.72180199 |
| 65 | Recurrent skin infections (HP:0001581) | 2.71632848 |
| 66 | Peripheral demyelination (HP:0011096) | 2.71312119 |
| 67 | Cerebral hypomyelination (HP:0006808) | 2.70166667 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.68494142 |
| 69 | Insidious onset (HP:0003587) | 2.67410897 |
| 70 | Termporal pattern (HP:0011008) | 2.67410897 |
| 71 | Cellulitis (HP:0100658) | 2.65570126 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.64054411 |
| 73 | White forelock (HP:0002211) | 2.62917886 |
| 74 | Pustule (HP:0200039) | 2.61701834 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.57714149 |
| 76 | Granulocytopenia (HP:0001913) | 2.57233997 |
| 77 | Patchy hypopigmentation of hair (HP:0011365) | 2.55105462 |
| 78 | Gingival bleeding (HP:0000225) | 2.54090530 |
| 79 | Gangrene (HP:0100758) | 2.53884412 |
| 80 | Alacrima (HP:0000522) | 2.53069774 |
| 81 | Intention tremor (HP:0002080) | 2.52931630 |
| 82 | Spastic tetraparesis (HP:0001285) | 2.52249877 |
| 83 | IgG deficiency (HP:0004315) | 2.50999000 |
| 84 | Eosinophilia (HP:0001880) | 2.50919576 |
| 85 | Increased IgE level (HP:0003212) | 2.50478233 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 2.49832909 |
| 87 | Epistaxis (HP:0000421) | 2.49201813 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.48586503 |
| 89 | Dysmetria (HP:0001310) | 2.45670656 |
| 90 | Abnormality of the prostate (HP:0008775) | 2.42816201 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.42734432 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.42333602 |
| 93 | Autoamputation (HP:0001218) | 2.41773905 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.41673613 |
| 95 | Premature skin wrinkling (HP:0100678) | 2.41632199 |
| 96 | Episodic fever (HP:0001954) | 2.41528845 |
| 97 | Stridor (HP:0010307) | 2.40863994 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.40707143 |
| 99 | Recurrent bronchitis (HP:0002837) | 2.39341525 |
| 100 | Abnormality of the pleura (HP:0002103) | 2.37324432 |
| 101 | Osteomyelitis (HP:0002754) | 2.34389638 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.32797589 |
| 103 | Severe combined immunodeficiency (HP:0004430) | 2.31211581 |
| 104 | Lymphopenia (HP:0001888) | 2.27029188 |
| 105 | Gastrointestinal inflammation (HP:0004386) | 2.25572353 |
| 106 | Polyneuropathy (HP:0001271) | 2.24961738 |
| 107 | Disinhibition (HP:0000734) | 2.23773106 |
| 108 | Anorexia (HP:0002039) | 2.23503906 |
| 109 | Leukodystrophy (HP:0002415) | 2.23383627 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 2.20086324 |
| 111 | Obstructive lung disease (HP:0006536) | 2.18842077 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18842077 |
| 113 | Chronic otitis media (HP:0000389) | 2.18555787 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.18541277 |
| 115 | Colitis (HP:0002583) | 2.17718689 |
| 116 | Absent septum pellucidum (HP:0001331) | 2.17686188 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17132353 |
| 118 | Thickened helices (HP:0000391) | 2.16134548 |
| 119 | Chronic diarrhea (HP:0002028) | 2.15526048 |
| 120 | Akinesia (HP:0002304) | 2.15523175 |
| 121 | Erythroderma (HP:0001019) | 2.13082487 |
| 122 | Glomerulopathy (HP:0100820) | 2.12735944 |
| 123 | Abnormality of B cell number (HP:0010975) | 2.12476731 |
| 124 | IgM deficiency (HP:0002850) | 2.12180651 |
| 125 | Retinal dysplasia (HP:0007973) | 2.12050449 |
| 126 | Vertigo (HP:0002321) | 2.11687295 |
| 127 | Sepsis (HP:0100806) | 2.07520287 |
| 128 | Amyloidosis (HP:0011034) | 2.07207807 |
| 129 | Urinary incontinence (HP:0000020) | 2.06885655 |
| 130 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06222853 |
| 131 | Thick nail (HP:0001805) | 2.05769319 |
| 132 | Anteriorly placed anus (HP:0001545) | 2.05568858 |
| 133 | Ankle clonus (HP:0011448) | 2.04744864 |
| 134 | Paraparesis (HP:0002385) | 2.04520854 |
| 135 | Hypoplasia of the iris (HP:0007676) | 2.04513380 |
| 136 | Combined immunodeficiency (HP:0005387) | 2.04451223 |
| 137 | Spastic paraparesis (HP:0002313) | 2.04231084 |
| 138 | Stomach cancer (HP:0012126) | 2.03019054 |
| 139 | Petechiae (HP:0000967) | 2.01250162 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00438234 |
| 141 | Hypoplastic pelvis (HP:0008839) | 2.00185304 |
| 142 | Abnormality of glycolysis (HP:0004366) | 2.00184353 |
| 143 | Increased serum pyruvate (HP:0003542) | 2.00184353 |
| 144 | Decreased lacrimation (HP:0000633) | 1.99942505 |
| 145 | Memory impairment (HP:0002354) | 1.95372662 |
| 146 | Metabolic alkalosis (HP:0200114) | 1.93752372 |
| 147 | Joint swelling (HP:0001386) | 1.92373681 |
| 148 | Premature loss of primary teeth (HP:0006323) | 1.90919995 |
| 149 | Foot dorsiflexor weakness (HP:0009027) | 1.88933424 |
| 150 | Amaurosis fugax (HP:0100576) | 1.88358320 |
| 151 | Osteolytic defects of the hand bones (HP:0009699) | 1.88119774 |
| 152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88119774 |
| 153 | Glomerulonephritis (HP:0000099) | 1.87841589 |
| 154 | Abnormality of the endocardium (HP:0004306) | 1.87357223 |
| 155 | Recurrent pneumonia (HP:0006532) | 1.86737734 |
| 156 | Skin rash (HP:0000988) | 1.85716265 |
| 157 | Scanning speech (HP:0002168) | 1.85197669 |
| 158 | Mutism (HP:0002300) | 1.83560104 |
| 159 | Muscle fiber splitting (HP:0003555) | 1.81502577 |
| 160 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81254839 |
| 161 | Duplicated collecting system (HP:0000081) | 1.80660164 |
| 162 | Abnormality of the septum pellucidum (HP:0007375) | 1.79608315 |
| 163 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.79512383 |
| 164 | Abolished electroretinogram (ERG) (HP:0000550) | 1.78414668 |
| 165 | Gowers sign (HP:0003391) | 1.75616758 |
| 166 | Hypophosphatemic rickets (HP:0004912) | 1.74837892 |
| 167 | CNS hypomyelination (HP:0003429) | 1.74736769 |
| 168 | Decreased motor nerve conduction velocity (HP:0003431) | 1.73948627 |
| 169 | Morphological abnormality of the inner ear (HP:0011390) | 1.72075462 |
| 170 | Partial duplication of thumb phalanx (HP:0009944) | 1.71544718 |
| 171 | Split foot (HP:0001839) | 1.69663525 |
| 172 | Purpura (HP:0000979) | 1.69257547 |
| 173 | Myokymia (HP:0002411) | 1.67920276 |
| 174 | J-shaped sella turcica (HP:0002680) | 1.66517530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.56315188 |
| 2 | OXSR1 | 3.98617847 |
| 3 | EPHB1 | 3.63703557 |
| 4 | PBK | 3.21119170 |
| 5 | PKN1 | 2.89543269 |
| 6 | TAOK3 | 2.62507768 |
| 7 | BLK | 2.48367993 |
| 8 | MAPKAPK5 | 2.43968348 |
| 9 | ZAP70 | 2.11194096 |
| 10 | BCR | 2.03325880 |
| 11 | MAP2K3 | 2.00994305 |
| 12 | GRK6 | 1.99254282 |
| 13 | CLK1 | 1.96989434 |
| 14 | CDK19 | 1.95873374 |
| 15 | LIMK1 | 1.90672830 |
| 16 | JAK3 | 1.90353556 |
| 17 | MET | 1.89271866 |
| 18 | WNK1 | 1.87202086 |
| 19 | FGR | 1.86393400 |
| 20 | MST4 | 1.85600133 |
| 21 | WNK4 | 1.79558534 |
| 22 | TESK2 | 1.73517517 |
| 23 | TEC | 1.67509174 |
| 24 | FGFR2 | 1.57934533 |
| 25 | MAP3K14 | 1.56523787 |
| 26 | TNK2 | 1.50913122 |
| 27 | NEK6 | 1.50212073 |
| 28 | JAK2 | 1.49668234 |
| 29 | MAP3K13 | 1.45858753 |
| 30 | CSNK1A1L | 1.45191005 |
| 31 | CAMKK2 | 1.45054727 |
| 32 | CSNK1G3 | 1.41794455 |
| 33 | IRAK4 | 1.36370176 |
| 34 | CAMK2B | 1.27522071 |
| 35 | CSF1R | 1.23436405 |
| 36 | RIPK4 | 1.23204837 |
| 37 | ROCK2 | 1.20226943 |
| 38 | GRK7 | 1.19949446 |
| 39 | MAP4K1 | 1.16209482 |
| 40 | UHMK1 | 1.16152090 |
| 41 | TRPM7 | 1.15499844 |
| 42 | ITK | 1.11792959 |
| 43 | ERN1 | 1.11743619 |
| 44 | MAP3K3 | 1.11213644 |
| 45 | PRPF4B | 1.08035121 |
| 46 | KIT | 1.07920452 |
| 47 | CAMK2D | 1.07504785 |
| 48 | PRKCQ | 1.05737500 |
| 49 | MAP3K11 | 1.05438174 |
| 50 | MATK | 1.05091044 |
| 51 | CSNK1G1 | 1.04803059 |
| 52 | IRAK2 | 1.03438061 |
| 53 | MAP3K1 | 1.00275720 |
| 54 | NTRK1 | 0.99680522 |
| 55 | IKBKB | 0.97231119 |
| 56 | ARAF | 0.95958440 |
| 57 | CSK | 0.94933140 |
| 58 | MAPK15 | 0.94077184 |
| 59 | MARK3 | 0.93003086 |
| 60 | TBK1 | 0.92060514 |
| 61 | KSR2 | 0.91877057 |
| 62 | CAMKK1 | 0.89612911 |
| 63 | CSNK1G2 | 0.89163094 |
| 64 | YES1 | 0.88888203 |
| 65 | BMPR1B | 0.88785947 |
| 66 | SIK3 | 0.88311099 |
| 67 | TXK | 0.87906955 |
| 68 | LCK | 0.82459877 |
| 69 | CAMK2G | 0.81455200 |
| 70 | PIK3CG | 0.81314914 |
| 71 | TYK2 | 0.80907185 |
| 72 | FES | 0.80011064 |
| 73 | IKBKE | 0.76921208 |
| 74 | PRKD1 | 0.76730375 |
| 75 | RPS6KA5 | 0.75006553 |
| 76 | BMPR2 | 0.74728719 |
| 77 | FGFR3 | 0.73744673 |
| 78 | PDPK1 | 0.73004209 |
| 79 | MOS | 0.71153156 |
| 80 | PNCK | 0.70745441 |
| 81 | SGK223 | 0.70597223 |
| 82 | SGK494 | 0.70597223 |
| 83 | ADRBK2 | 0.70408007 |
| 84 | TAOK1 | 0.69247739 |
| 85 | PAK6 | 0.68957921 |
| 86 | MAP3K2 | 0.68247775 |
| 87 | HCK | 0.67755334 |
| 88 | FYN | 0.67119071 |
| 89 | DYRK2 | 0.66704467 |
| 90 | MAPK12 | 0.63804813 |
| 91 | PIM1 | 0.63022500 |
| 92 | LYN | 0.62607315 |
| 93 | TGFBR2 | 0.60451313 |
| 94 | DAPK2 | 0.59002531 |
| 95 | MAP3K5 | 0.58260624 |
| 96 | GSK3A | 0.57400178 |
| 97 | TNIK | 0.56282250 |
| 98 | CAMK2A | 0.55235895 |
| 99 | ICK | 0.55227554 |
| 100 | SYK | 0.55122285 |
| 101 | STK10 | 0.55117091 |
| 102 | MAP2K6 | 0.54079358 |
| 103 | PRKCE | 0.54025275 |
| 104 | SGK2 | 0.52692090 |
| 105 | MUSK | 0.52402141 |
| 106 | CDK5 | 0.52006877 |
| 107 | NLK | 0.51928250 |
| 108 | SGK3 | 0.51587681 |
| 109 | DMPK | 0.51077780 |
| 110 | JAK1 | 0.50401624 |
| 111 | PDK1 | 0.50144820 |
| 112 | BTK | 0.49940398 |
| 113 | PRKCH | 0.49582779 |
| 114 | MARK2 | 0.49177930 |
| 115 | HIPK2 | 0.48941777 |
| 116 | TAOK2 | 0.48266808 |
| 117 | CASK | 0.47385514 |
| 118 | CDK14 | 0.47045539 |
| 119 | ACVR1B | 0.46440624 |
| 120 | BMX | 0.45408779 |
| 121 | PRKG1 | 0.44966578 |
| 122 | IRAK1 | 0.44417850 |
| 123 | IRAK3 | 0.44007806 |
| 124 | SIK2 | 0.43628380 |
| 125 | LRRK2 | 0.43254877 |
| 126 | CDK15 | 0.42299035 |
| 127 | MAP3K6 | 0.41511314 |
| 128 | PTK2B | 0.41153351 |
| 129 | MAPK7 | 0.40791451 |
| 130 | RAF1 | 0.39966933 |
| 131 | ABL1 | 0.39762476 |
| 132 | CDK6 | 0.39411255 |
| 133 | CSNK1D | 0.38657180 |
| 134 | MAP2K2 | 0.38579517 |
| 135 | CDK18 | 0.36099313 |
| 136 | INSR | 0.36046709 |
| 137 | ERBB4 | 0.35855999 |
| 138 | CAMK1G | 0.35722056 |
| 139 | CDK11A | 0.35316363 |
| 140 | STK11 | 0.35032044 |
| 141 | PAK1 | 0.34868149 |
| 142 | DAPK3 | 0.34815694 |
| 143 | MAP3K12 | 0.34563873 |
| 144 | RET | 0.33668845 |
| 145 | MAPKAPK2 | 0.32318831 |
| 146 | EGFR | 0.30575003 |
| 147 | PRKCD | 0.30106163 |
| 148 | CAMK4 | 0.28806421 |
| 149 | RPS6KL1 | 0.28452999 |
| 150 | RPS6KC1 | 0.28452999 |
| 151 | KSR1 | 0.28138154 |
| 152 | CDC42BPA | 0.27824603 |
| 153 | RPS6KA6 | 0.26209331 |
| 154 | DYRK1B | 0.26061951 |
| 155 | CHUK | 0.25541706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.03557674 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.00371849 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.58890202 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.99353034 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.77912522 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.26040051 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14863801 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06529756 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02382515 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.98597721 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98442235 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84081862 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.77493182 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71831161 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.70738683 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68281190 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.68051894 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66666782 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57682664 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54472009 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.54275106 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.53243392 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.44567723 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.41238391 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.41180754 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35680428 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34549231 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32035794 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31064644 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30238711 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27371189 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27137612 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24087166 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21726706 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17103702 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16658627 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16615507 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15071882 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15071624 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.14999820 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14456651 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12671936 |
| 43 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.11126398 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10711991 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09886761 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09814730 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09510555 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08445297 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07180412 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05394225 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01346546 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.98171833 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.96582873 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96005512 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95849452 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95702646 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93622183 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92257356 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90966345 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.89089574 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.89031487 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88579213 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.85861659 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83550168 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83212053 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83173377 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80303598 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79237575 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.76773727 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75091476 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.73309310 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.72984742 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72839451 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72799426 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71690779 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71552075 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71337621 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69681530 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69096881 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66586912 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65857391 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65029675 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64407499 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64058135 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62516403 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62214220 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61462217 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61185551 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60474269 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58818526 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58712212 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58351621 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.57241864 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56864268 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54443361 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53735284 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53602811 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52954275 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52546775 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52375487 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52310729 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52208397 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51942760 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50309022 |
| 105 | Long-term depression_Homo sapiens_hsa04730 | 0.50265277 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49755407 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45700846 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44353069 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44174607 |
| 110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43853238 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43830707 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43804963 |
| 113 | Morphine addiction_Homo sapiens_hsa05032 | 0.43674055 |
| 114 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43402392 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43393296 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43293661 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.43140878 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42108976 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41768642 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41159458 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40907215 |
| 122 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40222780 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39919211 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38018586 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37671481 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37249091 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37240256 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34686699 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34229484 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.31530205 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31000555 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30972702 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30440764 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29725073 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.29657862 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29297290 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29199959 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28902290 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.28662664 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28101741 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26948913 |
| 142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26751054 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23237696 |

